Palvella Therapeutics, Inc. (PVLA) bonds
PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$144.35−0.25 (-0.17%)
Close on Nov 17, 2026Market cap $2.08BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Palvella Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Palvella Therapeutics's 10-K for the period ended Dec 31, 2025
| Issue | Carrying value |
|---|---|
| Note 1 Convertible | $5.00M |
| Note 10 Convertible | $20.00K |
| Note 11 Convertible | $700.00K |
| Note 12 Convertible | $500.00K |
| Note 13 Convertible | $150.00K |
| Note 14 Convertible | $500.00K |
| Note 15 Convertible | $1.00M |
| Note 16 Convertible | $2.00M |
| Note 17 Convertible | $3.00M |
| Note 2 Convertible | $2.50M |
| Note 3 Convertible | $2.50M |
| Note 4 Convertible | $50.00K |
| Note 5 Convertible | $50.00K |
| Note 6 Convertible | $150.00K |
| Note 7 Convertible | $143.00K |
| Note 8 Convertible | $100.00K |
| Note 9 Convertible | $70.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?